Abstract:Abstract Background The Primary Breast Lymphomas (PBL) represent 0,38-0,70% of all non-Hodgkin lymphomas (NHL), 1,7-2,2% of all extranodal NHL and only 0,04-0,5% of all breast cancer. Most frequent PBLs are the diffuse large B cell lymphomas; in any case-reports MALT lymphomas lack or are a rare occurrence. Their incidence is growing. From 1880 (first breast resection for "lymphadenoid sarcoma" carried out by Gross) to the recent past the gold standard treatment for such diseases was surgery. At present such role has lost some of its importance, and it is matter of debate. Methods Twenty-three women affected by PBL underwent surgery. Average age was 63 years (range: 39-83). Seven suffered of hypothyroidism secondary to autoimmune thyroiditis. Fourteen patients underwent mastectomy, nine patients received quadrantectomy (average neoplasm diameter: 1,85 cm, range: 1,1-2,6 cm). In 10 cases axillary dissection was carried out. Pathologic examination revealed 16 diffuse large B cell lymphomas and 7 MALT lymphomas. Results Seven patients in the mastectomy group had a recurrence (50%), and all of them with diffuse large B cell lymphomas at stage II. Two of these had not received chemotherapy. No patient undergoing quadrantectomy had recurrence. In the mastectomy group disease free survival (DFS) at 5 and 10 years was 57 and 50%. Overall survival (OS) at 5 and 10 years was 71.4% and 57.1% respectively. All recurrences were systemic. DFS and OS at 5 and 10 years was 100% in the quadrantectomy group. In the patients with recurrence mortality was 85.7%. For stage IE DFS and OS at 5 and 10 years were 100%. For stage II DFS at 10 years was 62.5% and 56.2% respectively; OS at 5 and 10 years was 75% and 62.5% respectively. For MALT lymphomas DFS and OS at 5 and 10 years were 100%. For diffuse large B cell lymphomas DFS at 5 and 10 years was 62.5% and 56.2% respectively; OS at 5 and 10 years was 75% and 62,5% respectively. Conclusions The role of surgery in this disease should be limited to get a definitive diagnosis while for the staging and the treatment CT scan and chemio/radioterapy are repectively mandatory. MALT PBLs have a definitely better prognosis compared to large B cell lymphomas. The surgical treatment must always be oncologically radical (R0); mastectomy must not be carried out as a rule, but only when tissue sparing procedures are not feasible. Axillary dissection must always be performed for staging purposes, so avoiding the risk of under-staging II o IE, due to the possibility of clinically silent axillary node involvement.

Clinical analysis of 15 cases of primary breast lymphoma

Primary breast T-cell lymphoma, unspecified, treated with autologous peripheral blood stem cell transplantation: A case report and literature review.

[Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases]

Clinical Analysis of Primary Non-Hodgkin′s Lymphoma of Breast

[Mammographic, magnetic resonance imaging and clinicopathological characteristics of primary breast lymphoma]

[Clinical Analysis of 13 Patients with Primary Bone Lymphoma].

Analysis of Clinicopathologic Features and Prognosis in 10 Patients with Non-Epithelial Malignant Neoplasmas of the Larynx and Hypopharynx

Primary breast lymphoma: Clinical analysis of 32 cases

Primary breast lymphoma: long-term treatment outcome and prognosis.

Clinical Prognostic Risk Analysis and Progression Factor Exploration of Primary Breast Lymphoma

Clinical Characterization and Outcome of Primary Bone Lymphoma: a Retrospective Study of 61 Chinese Patients

Primary Breast Lymphoma: A Case Report of a Common Tumor in an Uncommon Location

Clinical and pathological characteristics of primary bone lymphoma

Primary Non-Hodgkin’s Lymphoma of the Breast: Eight-Year Follow-Up Experience

Primary breast lymphomas: a multicentric experience

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large BCell Lymphoma

Prognosis of primary non-Hodgkin's lymphoma of the breast]

Primary bone lymphoma: Clinical presentation and therapeutic considerations

Treatment outcome and prognosis in stage Ⅰ/Ⅱ primary non-Hodgkin lymphoma of the breast

Diagnoses and Treatment Reports of 11 Cases of Primary Malignant Lymphoma of Prostate

Understanding the Puzzle of Primary Breast Lymphoma: An Experience in a Tertiary Care Center in North India